Citadel Advisors’s Vir Biotechnology VIR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-40,800
Closed -$246K 14318
2025
Q4
$246K Buy
40,800
+22,300
+121% +$133K ﹤0.01% 10589
2025
Q3
$106K Sell
18,500
-2,100
-10% -$10.7K ﹤0.01% 11820
2025
Q2
$104K Sell
20,600
-8,300
-29% -$44.5K ﹤0.01% 11314
2025
Q1
$187K Buy
28,900
+7,700
+36% +$68.5K ﹤0.01% 10544
2024
Q4
$156K Sell
21,200
-10,200
-32% -$80.5K ﹤0.01% 10823
2024
Q3
$235K Buy
31,400
+10,800
+52% +$93.8K ﹤0.01% 9824
2024
Q2
$183K Sell
20,600
-7,500
-27% -$71.9K ﹤0.01% 10064
2024
Q1
$285K Buy
28,100
+6,700
+31% +$68.2K ﹤0.01% 9564
2023
Q4
$215K Sell
21,400
-17,600
-45% -$161K ﹤0.01% 9811
2023
Q3
$365K Sell
39,000
-5,500
-12% -$78.4K ﹤0.01% 8742
2023
Q2
$1.09M Buy
44,500
+12,000
+37% +$301K ﹤0.01% 6283
2023
Q1
$756K Sell
32,500
-16,700
-34% -$427K ﹤0.01% 7395
2022
Q4
$1.25M Sell
49,200
-3,400
-6% -$83.3K ﹤0.01% 6390
2022
Q3
$1.01M Sell
52,600
-5,400
-9% -$137K ﹤0.01% 6965
2022
Q2
$1.48M Sell
58,000
-96,600
-62% -$2.26M ﹤0.01% 6159
2022
Q1
$3.98M Sell
154,600
-44,200
-22% -$1.31M ﹤0.01% 4624
2021
Q4
$8.32M Buy
198,800
+114,300
+135% +$4.48M ﹤0.01% 3366
2021
Q3
$3.68M Buy
84,500
+13,500
+19% +$584K ﹤0.01% 4921
2021
Q2
$3.36M Sell
71,000
-3,500
-5% -$159K ﹤0.01% 5331
2021
Q1
$3.82M Buy
74,500
+14,000
+23% +$755K ﹤0.01% 4878
2020
Q4
$1.62M Buy
60,500
+37,800
+167% +$1.23M ﹤0.01% 5825
2020
Q3
$779K Sell
22,700
-7,900
-26% -$340K ﹤0.01% 6488
2020
Q2
$1.25M Buy
+30,600
New +$1.03M ﹤0.01% 5411

Other funds holding VIR